Table 1 Clinical characteristics according to gender status
Whole cohort (n = 793) | Male (n = 571) | Female (n = 222) | P value | |
|---|---|---|---|---|
Age | 65.1 (15) | 64.2 (14) | 67.3 (16) | 0,013 |
BMI | 26.9 (5) | 27 (4) | 26.7 (6) | 0.537 |
Diabetes mellitus | 314 (39.6) | 226 (39.6) | 88 (39.6) | 0.988 |
Hypertension | 466 (58.8) | 331 (58) | 135 (61.1) | 0.424 |
Dyslipidemia | 446 (56.2) | 329 (57.6) | 117 (52.7) | 0.210 |
Active smoker | 219 (27.7) | 190 (33.4) | 29 (13.1) | 0.001 |
COPD | 130 (16.4) | 108 (18.9) | 22 (9.9) | 0.002 |
Prior stroke | 69 (8.7) | 54 (9.5) | 15 (6.8) | 0.226 |
PAD | 90 (11.3) | 71 (12.4) | 19 (8.6) | 0.122 |
Prior MI | 159 (20.1) | 126 (22.1) | 33 (14.9) | 0.023 |
Prior PCI | 96 (12.1) | 74 (13) | 22 (9.9) | 0.485 |
Prior CABG | 33 (4.2) | 24 (4.2) | 9 (4.1) | 0.789 |
Renal failure | 134 (16.9) | 104 (18.2) | 30 (13.5) | 0.113 |
Previous heart failure | 213 (26.9) | 150 (26.3) | 63 (28.5) | 0.524 |
ACS-related cardiogenic shock | 501 (63.2) | 373 (65.3) | 128 (57.7) | 0.044 |
Systolic blood pressure | 81 (16) | 81 (16) | 80 (15) | 0.969 |
Heart rate | 94 (28) | 94 (29) | 93 (27) | 0.459 |
Cardiac arrest | 176 (22.2) | 132 (23.1) | 44 (19.9) | 0.330 |
Sinus rythm | 565 (72.3) | 404 (71.6) | 161 (74.2) | 0.473 |
LVEF (%) | 32 (13) | 31 (13) | 34 (13) | 0.003 |
Confusion at presentation | 486 (61.4) | 352 (61.8) | 134 (60.4) | 0.717 |
Lactate | 0.056 | |||
< 2 mmol/L | 169 (23.8) | 128 (24.9) | 41 (21) | |
2–4 mmol/L | 213 (30) | 162 (31.5) | 51 (26.2) | |
> 4 mmol/L | 328 (46.2) | 225 (43.7) | 103 (52.8) | |
Glucose > 191 mg/dL | 357 (46.9) | 252 (45.8) | 105 (49.8) | 0,329 |
eGFR (ml/min/1.73 m2) | 0.027 | |||
< 30 | 146 (24.3) | 90 (20.9) | 56 (32.7) | |
30–60 | 271 (45) | 205 (47.6) | 66 (38.6) | |
> 60 | 185 (30.7) | 136 (31.6) | 49 (28.7) | |
CardShock score value | 4.7 (1.7) | 4.7 (1.7) | 4.8 (1.8) | 0.501 |
IABP II score value | 2.5 (1.8) | 2.5 (1.8) | 2.6 (1.8) | 0.525 |